Shire PLC

Pharmaceuticals
Ireland
Earnings Per Share Growth (%)-61.86%
Cost of Goods Sold (US$ Millions)$969
Current Liabilities (US$ Millions)$3,706
Total Assets (US$ Millions)$2,256
Long Term Debt$70
Return on Equity15.05%
Revenue (US$ Millions)$6,417
Total Company Assets$16,610
Revenue Growth (%)6.55%
Net Income (US$ Millions)$1,303
Earnings Per Share (US$)($61.86)
Total Equity (US$ Millions)$9,829
Profit Margin (%)20.31%
Debt To Equity Ratio (%)0.01%
Inventory Turnover$635